Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishen Jiangzhuo therapy
- Development stage
- Unknown
- Lead developer
- Tianjin Institute of Pharmaceutical Research
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Yishen Jiangzhuo therapy (YJG) is a Traditional Chinese Medicine (TCM) multi-herb granule formulation developed for the treatment of renal anemia and chronic kidney disease (CKD), particularly in non-dialysis patients at stages 3–4. The formulation consists of a complex botanical mixture including *Radix Pseudostellariae* (Taizishen), *Poria* (Fuling), *Rhizoma Atractylodis Macrocephalae* (Baizhu), *Radix Astragali Mongolici* (Huangqi), *Herba Taxilli Chinensis* (Sangjisheng), *Fructus Mori* (Sangshen), *Radix et Rhizoma Rhei Palm* (Dahuang), and *Herba Serissae Japonicae* (Liuyuexue). It is primarily studied by the Hebei Provincial Administration of Traditional Chinese Medicine as an add-on to standard Western medical care. Its therapeutic effects are attributed to the synergistic action of its multiple herbal constituents, which have been shown to influence immunity, bone metabolism, fibroblast growth factor 23 (FGF23) levels, and erythropoiesis-related parameters.
- Other names
- Yishen Jiangzhuo Granule
02
Targets
TGFB1 (Transforming growth factor Beta-1 proprotein)RK (Ribokinase)MAPK3 (Mitogen-activated protein kinase 1)
Beyond the preview
Go deeper on Yishen Jiangzhuo therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yishen Jiangzhuo therapy.